Active Citizenship Network is delighted to invite you to the event “Securing Equitable Patient Access to Advanced Therapies across Europe”
that will be held on October 24th, 2022 from 16:00 to 18:00 CEST in room JAN 6Q1 at the European Parliament in Brussels.
Kindly hosted by the Member of the European Parliament Tomislav Sokol (EPP group), co-chair of the MEPs Interest Group “European Patients' Rights and Cross-border Healthcare”, the initiative is organized by Active Citizenship Network, the EU branch of Cittadinanzattiva, with the aim of contributing to provide a multi-stakeholder vision for equitable patient access to ATMPs.
Together with European institutions, academia, healthcare professionals, citizen organizations & Patient Advocacy Groups (PAGs), the private sector and key stakeholders, we will discuss the disruptive aspects of ATMPs and pay attention to the opportunities and challenges of new advanced therapies, which are expected to increase significantly over the next decade: an encouraging but equally challenging scenario, considering the high costs and public budget constraints faced by several EU countries. Aspects that must be addressed today in order not to be unprepared tomorrow.
The starting point is that the traditional reimbursement and budgeting schemes are unable to amortize the value of ATMPs, whose costs and benefits are not aligned. These types of therapies need new and different payment and accounting methods, which take into account the high initial costs and the large and lasting benefits over time, both for the patients and for the national health systems. It is time for an institutional mindset change to classify ATMPs expenditure as an investment and not a cost.
How can European institutions facilitate this process? What decisions are taken at the level of each Member State to make these therapies accessible to the largest number of eligible patients? What role do PAGs play? On this occasion, the Call to Action “Advanced Therapies Medicinal Products revolution & the respect of the patients’ right to access to care”, so far endorsed by 42 PAGs, will be officially presented at European level.
The event is realized in the framework of the European activities organized by Cittadinanzattiva with the unconditional support of the #VITA – Value and Innovation of Advanced Therapiescoalition, coordinated by the global law firm LS CUBE.
To know more:
Technical Policy Report from the #VITA Working Group “The economic evaluation of advanced therapy medicinal products: characteristics and reasons for a new economic and accounting approach” (EN – IT).